Literature DB >> 1556520

Prevalence of hyperinsulinaemia in patients with high blood pressure.

I Zavaroni1, S Mazza, E Dall'Aglio, P Gasparini, M Passeri, G M Reaven.   

Abstract

A total of 41 patients with hypertension were identified in a survey of 732 healthy factory workers. Twenty-three of these individuals were receiving antihypertensive medication, whereas 18 cases were newly discovered. Plasma glucose and insulin responses to oral glucose and fasting plasma triglyceride (TG), cholesterol, and high-density-lipoprotein (HDL) cholesterol concentrations of these 41 individuals were compared with those of 41 other factor workers, with normal blood pressure, matched with the hypertensive group in terms of gender, age, degree of obesity, job in the factory, and leisure-time activity. Patients with hypertension had significantly higher plasma glucose (P less than 0.05) and insulin (P less than 0.05) concentrations in response to oral glucose, as well as a higher plasma TG concentration (P less than 0.05). Similar findings were obtained when the treated and untreated hypertensive groups were analysed separately and compared with their respective control groups. However, there were no differences between the treated and untreated hypertensive groups. Ninety per cent of the normotensive group had a plasma insulin concentration of less than 500 pmol l-1 2 h after the glucose load. Using this value as the criterion for definition of hyperinsulinaemia, 41% of the patients with high blood pressure were hyperinsulinaemic. In addition to meeting this cut-off point, the patients with hypertension and hyperinsulinaemia were also glucose intolerant and dyslipidaemic. In conclusion, approximately 50% of an unselected group of patients with hypertension were hyperinsulinaemic. Insulin levels were comparable in treated and untreated patients with high blood pressure, and hyperinsulinaemic patients also tended to be glucose intolerant and dyslipidaemic.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1556520     DOI: 10.1111/j.1365-2796.1992.tb00529.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  18 in total

1.  Quantitative trait loci influencing cholesterol and phospholipid phenotypes map to chromosomes that contain genes regulating blood pressure in the spontaneously hypertensive rat.

Authors:  A Bottger; H A van Lith; V Kren; D Krenová; V Bílá; J Vorlícek; V Zídek; A Musilová; M Zdobinská; J M Wang; B F van Zutphen; T W Kurtz; M Pravenec
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Plasma adiponectin and insulin resistance in new onset hypertension.

Authors:  Teoman Dogru; Alper Sonmez; Ilker Tasci; M Ilker Yilmaz; Selim Kilic; Taner Ozgurtas; Tayfun Eyileten; M Kemal Erbil; I Hakki Kocar
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

3.  Blood pressure in 15 inbred mouse strains and its lack of relation with obesity and insulin resistance in the progeny of an NZO/HILtJ x C3H/HeJ intercross.

Authors:  Chieko Tsukahara; Fumihiro Sugiyama; Beverly Paigen; Satoshi Kunita; Ken-Ichi Yagami
Journal:  Mamm Genome       Date:  2004-12       Impact factor: 2.957

4.  The antihypertensive effect of cysteine.

Authors:  Sudesh Vasdev; Pawan Singal; Vicki Gill
Journal:  Int J Angiol       Date:  2009

Review 5.  Risk factors preceding type 2 diabetes and cardiomyopathy.

Authors:  Shamjeet Singh; Sanjiv Dhingra; Dan D Ramdath; Sudesh Vasdev; Vicki Gill; Pawan K Singal
Journal:  J Cardiovasc Transl Res       Date:  2010-07-01       Impact factor: 4.132

6.  Relationship among 25-hydroxyvitamin D concentrations, insulin action, and cardiovascular disease risk in patients with essential hypertension.

Authors:  Fahim Abbasi; David Feldman; Michael P Caulfield; Feras M Hantash; Gerald M Reaven
Journal:  Am J Hypertens       Date:  2014-08-19       Impact factor: 2.689

7.  Inhibition of matrix metalloproteinase-2 improves endothelial function and prevents hypertension in insulin-resistant rats.

Authors:  P R Nagareddy; P S Rajput; H Vasudevan; B McClure; U Kumar; K M Macleod; J H McNeill
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

8.  Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies.

Authors:  Abigail May Khan; Susan Cheng; Martin Magnusson; Martin G Larson; Christopher Newton-Cheh; Elizabeth L McCabe; Andrea D Coviello; Jose C Florez; Caroline S Fox; Daniel Levy; Sander J Robins; Pankaj Arora; Shalender Bhasin; Carolyn S P Lam; Ramachandran S Vasan; Olle Melander; Thomas J Wang
Journal:  J Clin Endocrinol Metab       Date:  2011-08-17       Impact factor: 5.958

9.  The Metabolic Syndrome in Patients With Severe Mental Illnesses.

Authors:  Patrick Toalson; Saeeduddin Ahmed; Thomas Hardy; Gary Kabinoff
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

Review 10.  Molecular Mechanisms of Sodium-Sensitive Hypertension in the Metabolic Syndrome.

Authors:  Jonathan M Nizar; Vivek Bhalla
Journal:  Curr Hypertens Rep       Date:  2017-08       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.